LOS ANGELES The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc, Eli Lilly and Co and other makers of new migraine medicines to try and fix it.
- Wounded soldier gets world's first penis transplant in U.S. operation |
- FDA cracks down on sales of Juul tobacco products to minors
- AstraZeneca flop a fresh blow to cancer immunotherapy combination
- UK bans Sanofi epilepsy drug without pregnancy prevention plan
- For elderly, opioids tied to higher risk of fall-related injuries and deaths
(Reuters Health) - Pregnant women who drink lots of coffee and other caffeinated beverages may be more likely to have kids who are overweight than mothers who limit caffeine during pregnancy, a Norwegian study suggests.
(Reuters Health) - People who have a lot of trouble hearing may be almost twice as likely to experience an accidental injury as individuals with excellent or good hearing, a U.S. study suggests.
GENEVA Malaria is spreading rapidly in crisis-hit Venezuela, with more than an estimated 406,000 cases in 2017, up roughly 69 percent from a year before, the largest increase worldwide, the World Health Organization (WHO) said on Tuesday.
Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias Zerhouni retires from the French drugmaker.